Skip to main content
2025 CRT Conference Main banner

CRT 2025

Evening Symposium

Program Director Symposium

Attendee - Fellowship Program Director Symposium [Non-CME]

Saturday, March 8, 2025
6:30 PM - 8:45 PM ET

    Roundtable Participant(s)

  • Paul T. Campbell, MD

    Interventional Cardiologist
    Sanger Heart & Vascular Institute
    Concord , North Carolina, United States

    Disclosure(s): No financial relationships to disclose

  • James DeVries, MD

    Director, Interventional Cardiology Fellowship Training Program
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire, United States

    No relationships to disclose

  • ME

    Marvin Eng, MD

    Structural Heart Disease Medical Director
    Banner University Medical Center
    Phoenix, Arizona, United States

    Disclosure information not submitted.

  • Uzoma N. Ibebuogu, MD

    Professor of Medicine
    University of Tennessee
    Memphis , Tennessee, United States

    No relationships to disclose

  • Rony Lahoud, MD

    Associate Professor
    University of Vermont
    S. Burlington, Vermont, United States

    Disclosure information not submitted.

  • Daniel S. Menees, MD

    Director, Interventional Cardiology Fellowship Program
    University of Michigan, Michigan, United States

    Disclosure(s): No financial relationships to disclose

  • Bibhu D. Mohanty, MD

    Associate Professor of Medicine
    University of South Florida / Tampa General Hospital

    No relationships to disclose

  • UR

    Umamahesh C. Rangasetty, MD

    Interventional cardiologist
    University of Texas Medical branch at Galveston, Texas, United States

    No relationships to disclose

Disclosure(s):
Babak Azarbal, MD: No financial relationships to disclose
Paul T. Campbell, MD: No financial relationships to disclose
James DeVries, MD: No financial relationships to disclose
Ashequl M. Islam, MD: No financial relationships to disclose
Uzoma N. Ibebuogu, MD: No financial relationships to disclose
Daniel S. Menees, MD: No financial relationships to disclose
Bibhu D. Mohanty, MD: Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing)
Umamahesh C. Rangasetty, MD: Abbott Cardiovascular Systems: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards, Medtronic, Boston Scientific: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Moderna: Stock-publicly held company (excluding mutual/index funds) (Terminated); Pfizer: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Philips-Spectranetics: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Daniel R. Schimmel, MD, MS: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Terminated, November 1, 2023), Grant/Research Support (Terminated, November 1, 2023); Avnetus: Consultant (Ongoing), Grant/Research Support (Ongoing); Inari: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)